This is the third patient to be cured of AIDS thanks to a bone marrow transplant which has made it possible to renew his immune system in depth.
This is a new official case of recovery from HIV following a bone marrow transplant: the “Dusseldorf patient” no longer has any trace of the virus in his body, indicate work published Monday in Nature Medicine. Only two similar recovery cases have been described so far in scientific publications: the patient from Berlin in 2009 and the patient from London in 2019.
Two other cases of cures were detailed last year during scientific conferences, but have not yet given rise to publications in due form.
Immune system renewal
This third patient, a man followed in Düsseldorf, received a stem cell transplant to treat leukemia, then was able to interrupt his antiretroviral treatment once morest HIV, described the international consortium IciStem, of which the Institut Pasteur is a partner, in the ‘study.
In their analyses, the researchers did not find viral particles, nor an activatable viral reservoir, nor immune responses once morest the virus in the organism of this person despite the cessation of treatment for 4 years.
The cured patients all have a very particular situation in common. They were suffering from blood cancers and benefited from a stem cell transplant which deeply renewed their immune system. Their donor had a rare mutation in a gene called CCR5, a genetic mutation known to prevent HIV from entering cells.
Double healing success
“During a bone marrow transplant, the patient’s immune cells are completely replaced by those of the donor, which makes it possible to make the vast majority of infected cells disappear”, explains, in a press release, the virologist Asier Sáez-Cirión. , one of the authors of the study.
“This is an exceptional situation when all these factors coincide for this transplant to be a double success in curing leukemia and HIV,” said the researcher.
Since less than 1% of the general population carries this HIV protective mutation, it is indeed very rare for a compatible marrow donor to have this mutation. In 2018, the medical team no longer detected the presence of the virus and planned with the patient a supervised discontinuation of antiretroviral treatment once morest HIV.
But if these cases of remission bring hope to researchers of one day overcoming HIV, a bone marrow transplant remains a very heavy and risky operation: it is not adaptable to most carriers of the virus.
